Events – Page 2

Events

2019 Early Career Investigator Workshop – Registration Now Open

14 June 2019 /

The Early Career Investigator’s Workshop, to be held in Cordoba, Spain on 4th October 2019, is now open for registration. Topics to be featured at the Workshop include the diagnosis of PMP, the EuroPMP COST Action, selected topics from PMP experimentation, and the surgical treatment of PMP. Included in the day’s activities will be a session dedicated to the work being undertaken by Early Career Investigators themselves, with posters and lightning talks being presented. The workshop is specifically targeted at younger researchers working in on projects related to pseudomyxoma peritonei and will be a comprehensive and interesting conference for any young researcher working with PMP. The programme for the Workshop…

Read More
Events

EuroPMP Represented at Spain’s GECOP

7 June 2019 /

The national meeting of GECOP (the Spanish group for peritoneal oncological surgery) was held in Murcia, Spain on 7th June 2019. GECOP was pleased to count Professor Norman Carr (UK) at their meeting. Prof Carr explained the importance of the EuroPMP project to the consolidation of the PSOGI consensus in pathology of PMP, as well as giving information about the EuroPMP Action itself. Dr Paul Sugarbaker, Dr Mohammad Alyami, Dr Olivia Sgarbura, and Dr Marcello Deraco were also in attendance at the meeting, discussing all the issues around peritoneal surface malignancies.

Read More

Health related quality of life is excellent and sustained at two decades after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in survivors of pseudomyxoma peritonei of appendiceal origin.(Read paper)
Recurrence after cytoreductive surgery and HIPEC for pseudomyxoma peritonei: A single-center retrospective cohort study.(Read paper)
Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study.(Read paper)
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.(Read paper)
External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification.(Read paper)
A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei.(Read paper)
Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation.(Read paper)
Pseudomyxoma Peritonei Arising from Urachal Mucinous Neoplasms: a Case Series and Updated Literature Review.(Read paper)
Long-Term Survival in Patients Treated by Cytoreductive Surgery with or Without HIPEC for Peritoneal Surface Malignancies-A report from the Indian HIPEC Registry.(Read paper)
Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin.(Read paper)